Margit Mahlapuu
Directeur Général chez ScandiCure AB
Profil
Margit Mahlapuu is the founder of ScandiCure AB, which was founded in 2016.
She is currently the Chairman & Chief Executive Officer of Arexela AB, the Chief Executive Officer of Alexera AB, the Managing Director of Pergamum AB, the Director & Chief Scientific Officer of Sixera Pharma AB, and a Professor-Molecular Medicine at the University of Gothenburg.
Her former positions include being a Post Doctoral Fellow at AstraZeneca AB, a Project Manager-Research & Development at Biovitrum AB, a Project Leader at Arexis AB, and the Chief Scientific Officer at both Promore Pharma AB and PharmaSurgics In Sweden AB.
She received a doctorate degree from the University of Gothenburg.
Postes actifs de Margit Mahlapuu
| Sociétés | Poste | Début |
|---|---|---|
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Corporate Officer/Principal | - |
ScandiCure AB
 ScandiCure AB Pharmaceuticals: MajorHealth Technology ScandiCure AB develops anti-diabetic drug based on small molecule antagonists of a novel key mediator. The company was founded by Margit Mahlapuu on August 8, 2016 and is headquartered in Göteborg, Sweden. | Directeur Général | 08/08/2016 |
Sixera Pharma AB
 Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Directeur Technique/Scientifique/R&D | - |
Arexela AB
 Arexela AB Miscellaneous Commercial ServicesCommercial Services Arexela AB provides scientific and technical research and development services. The CEO of the Swedish company is Margit Mahlapuu. | Directeur Général | - |
Alexera AB
 Alexera AB Real Estate DevelopmentFinance Alexera AB owns and manages healthcare related discoveries and inventions. The company is headquartered in Gothenburg, Sweden. | Directeur Général | - |
| University of Gothenburg | Corporate Officer/Principal | - |
Anciens postes connus de Margit Mahlapuu
| Sociétés | Poste | Fin |
|---|---|---|
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Corporate Officer/Principal | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01/01/2002 |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░░░ ░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Formation de Margit Mahlapuu
| University of Gothenburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Health Technology |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
PharmaSurgics In Sweden AB
 PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Health Technology |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Health Technology |
ScandiCure AB
ScandiCure AB Pharmaceuticals: MajorHealth Technology ScandiCure AB develops anti-diabetic drug based on small molecule antagonists of a novel key mediator. The company was founded by Margit Mahlapuu on August 8, 2016 and is headquartered in Göteborg, Sweden. | Health Technology |
Arexela AB
Arexela AB Miscellaneous Commercial ServicesCommercial Services Arexela AB provides scientific and technical research and development services. The CEO of the Swedish company is Margit Mahlapuu. | Commercial Services |
Alexera AB
Alexera AB Real Estate DevelopmentFinance Alexera AB owns and manages healthcare related discoveries and inventions. The company is headquartered in Gothenburg, Sweden. | Finance |